Neuland Laboratories has declared a final dividend of ₹34 per share for the financial year 2025-26, representing a 340% payout on the face value of ₹10 per share. The dividend is set to be disbursed following shareholder approval at the company’s 42nd Annual General Meeting (AGM), scheduled for August 4, 2026. The record date to determine eligible shareholders for the dividend is July 24, 2026.
In addition to the dividend announcement, Neuland Laboratories‘ Board of Directors approved a significant capacity expansion at its Unit 1, located in Bonthapally Village, Telangana. The expansion will increase the facility’s capacity by 120.5 kilolitres, bringing the total capacity to 376.5 kilolitres. This expansion, aimed at meeting growing customer demand, is expected to be completed within 12 to 18 months. The project will require an investment of ₹143.4 crores, which will be financed through internal accruals and borrowings.
The board also approved the appointment of Dr. Mauricio Futran as an Additional Director, classified as Non-Executive Non-Independent, effective from May 12, 2026. His appointment is subject to shareholder approval at the forthcoming AGM.
The company’s financial results for the year ended March 31, 2026, were approved by the board. The results, audited by M S K A & Associates LLP, received an unmodified opinion.
Disclaimer: This article is based on a regulatory filing submitted to the National Stock Exchange of India (NSE).